Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03513523 · ClinicalTrials.gov registry record · NA
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
A NA study of Fatty Liver, sponsored by Elysium Health.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
- 9
- Study locations
NCT03513523 is a NA study of Fatty Liver that has completed, run by Elysium Health. The registered enrollment target is 111 participants, below the 205-participant average among 20 other Fatty Liver trials with a reported enrollment target (46% lower). The trial reports 9 study locations across 3 states.
The verdict
NCT03513523, a NA study of Fatty Liver, has completed, sponsored by Elysium Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to determine if there is a relationship between daily consumption of NRPT, over a six-month (26-week) period, and changes in liver fat accumulation, compared to placebo and change from Baseline in healthy volunteers. In addition, an exploratory assessment of markers of inflammation and liver fat metabolism will be examined.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Group 1 NRPT
- DIETARY_SUPPLEMENT Group 2 NRPT
- OTHER Group 3 Placebo
Study Locations (9)
Florida
- Indago Research and Health Center - Hialeah
- Altus Research, Inc. - Lake Worth
- Lone Star Research Center - Miami
- Med-Care Research Corp - Miami
- Legacy Clinical Solutions: Sensible Healthcare, LLC - Ocoee
- IMIC, Inc - Palmetto Bay
- Lenus Research & Medical Group - Sweetwater
Nebraska
- Barrett Clinic, P.C. - La Vista
North Carolina
- Trial Management Associates, LLC - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2020-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03513523
The ClinicalTrials.gov registry entry for NCT03513523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 20 other Fatty Liver trials with a reported enrollment target (46% lower). The listed sponsor is Elysium Health, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fatty Liver appearing as the primary indexed condition, and to 3 interventions - of which Group 1 NRPT is the first listed.
NCT03513523 reports 9 study locations spanning 3 distinct geographic areas - top geographies include Florida, Nebraska, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03513523 about?
NCT03513523 is a clinical study titled "Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers". The purpose of this study is to determine if there is a relationship between daily consumption of NRPT, over a six-month (26-week) period, and changes in liver fat accumulation, compared to placebo and change from Baseline in healthy volunteers. In addition, an exploratory assessment of markers of i...
What is the current status of trial NCT03513523?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2018-04-18. Estimated completion is 2020-08-17.
What conditions does trial NCT03513523 study?
This clinical trial studies the following conditions: Fatty Liver.
What interventions are being tested in trial NCT03513523?
The interventions under investigation include: Group 1 NRPT (DIETARY_SUPPLEMENT), Group 2 NRPT (DIETARY_SUPPLEMENT), Group 3 Placebo (OTHER).
Who is sponsoring clinical trial NCT03513523?
This trial is sponsored by Elysium Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03513523 being conducted?
This trial has 9 study locations across Florida, Nebraska, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatty Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Relation of Obesity With Frequency of Meals (MST 0557)
COMPLETED · NA
-
Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults
COMPLETED · NA
-
Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease
COMPLETED · NA
-
Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol
COMPLETED · NA
-
Early Tracking of Childhood Health Determinants (ETCHED) Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.